Telix Opens Australia’s First Integrated Radiopharmaceutical Facility for Cancer Care
MELBOURNE, Australia & INDIANAPOLIS, Ind., July 16, 2026 Telix has officially opened Telix Manufacturing Solutions North Melbourne (TMSNM), Australia’s...
Capital for New Therapy
Senhwa Biosciences Secures NT$500M GEM Investment Deal
TAIPEI, Taiwan & SAN DIEGO, Calif., July 14, 2026 Senhwa Biosciences, Inc. has entered into a significant financing agreement...
Angelini Ventures Invests in Handspring Health Series B
BOSTON, Mass., July 7, 2026 Handspring Health has secured $19 million in Series B financing, with Angelini Ventures participating...
Healome Therapeutics Secures £2M to Advance Eye Drop Technology
BIRMINGHAM, United Kingdom, July 7, 2026 Healome Therapeutics, a University of Birmingham spinout developing an innovative eye-drop matrix technology...
Regal Healthcare Capital Closes $610 Million Fund IV
NEW YORK, July 7, 2026 Regal Healthcare Capital Partners has successfully completed the final close of Fund IV, securing...
Oryzon Raises €12M to Accelerate Clinical Development
MADRID, Spain & CAMBRIDGE, Mass., July 1, 2026 Oryzon Genomics S.A. announced the successful completion of a €12 million...
ARTAN Bio Secures $1M Seed Round for tRNA Platform
ST. PETERSBURG, Fla., July 1, 2026 ARTAN Bio has announced the successful completion of a $1 million seed financing...
Telum Therapeutics Raises €18M Series A for AMR Program
SPAIN, July 1, 2026 Telum Therapeutics announced the successful completion of an €18 million Series A financing round to...
CraniUS Secures NIH Grant for Glioblastoma Therapy
BALTIMORE, June 29, 2026 CraniUS Therapeutics has received an initial $1.1 million award through the National Institutes of Health...
Siren Biotechnology Secures $8M CIRM Grant for SRN-101 Trial
SAN FRANCISCO, Calif., June 26, 2026 Siren Biotechnology has been awarded an $8 million non-dilutive CLIN2 grant from the...